A) ABSTRACT / HEADNOTE

The Supreme Court of India addressed a significant issue involving Patanjali Ayurved Limited, led by its Managing Director, Acharya Balkrishna, and Baba Ramdev. The case focused on allegations of contempt of court for breaching an undertaking given to the Court under the Contempt of Courts Act, 1971. The Court examined whether the defendants’ actions—including advertising false medical claims—constituted wilful disobedience. Despite their initial noncompliance and continued misleading practices, the Court accepted their unqualified apology after they demonstrated sincere efforts to rectify their actions. This case highlights the rigorous standards courts maintain to ensure their orders are respected and underscores the judiciary’s power to enforce accountability.

Keywords:

1. Contempt of Court
2. Misleading Advertisements
3. Patanjali Ayurved Limited
4. Drugs and Magic Remedies Act
5. Undertaking Breach

B) CASE DETAILS

i) Judgment Cause Title:
Indian Medical Association and Another v. Union of India and Others

ii) Case Number:
Suo Motu Contempt Petition (Civil) No. 4 of 2024

iii) Judgment Date:
13 August 2024

iv) Court:
Supreme Court of India

v) Quorum:
Justice Hima Kohli and Justice Ahsanuddin Amanullah

vi) Author of Judgment:
Justice Hima Kohli

vii) Citation:
[2024] 8 S.C.R. 401

viii) Legal Provisions Involved:

• Contempt of Courts Act, 1971
• Drugs and Magic Remedies (Objectionable Advertisement) Act, 1954
• Drugs and Magic Remedies (Objectionable Advertisement) Rules, 1955
• Article 129 of the Constitution of India

ix) Judgments Overruled by the Case:
None explicitly overruled.

x) Case is Related to:
Contempt Law, Regulatory Advertising Law, Medical Ethics

C) INTRODUCTION AND BACKGROUND OF JUDGMENT

The dispute originated from allegations by the Indian Medical Association (IMA) accusing Patanjali Ayurved Limited and its directors of publishing advertisements that violated the Drugs and Magic Remedies Act, 1954. The IMA claimed these advertisements misled the public by making unverified claims about cures for serious diseases like diabetes, blood pressure, and asthma. These allegations were compounded by press conferences where Baba Ramdev made statements disparaging modern medicine and promoting their products as definitive solutions to ailments.

Despite giving an undertaking to the Supreme Court to cease these practices, Patanjali violated the terms the very next day. This blatant disregard led to suo motu contempt proceedings.

D) FACTS OF THE CASE

1. Misleading Advertising:
   Patanjali issued advertisements claiming their medicines provided permanent cures for conditions prohibited under the Drugs and Magic Remedies Act.

2. Press Conferences:
   On November 22, 2023, Baba Ramdev held a press conference reiterating the same false claims despite the undertaking to the Court.

3. Court’s Interim Order:
   On November 21, 2023, the Court had explicitly prohibited advertising or branding products in contravention of existing laws.

4. Subsequent Developments:
   In December 2023, Patanjali published further advertisements, continuing the misrepresentation of their products, leading to a show cause notice for contempt.

E) LEGAL ISSUES RAISED

i) Whether the actions of Patanjali Ayurved Limited and its directors constituted wilful breach of the Court’s undertaking under the Contempt of Courts Act, 1971.
ii) Whether the apology tendered by the contemnors met the threshold for an unconditional apology.
iii) The scope of liability for actions breaching the Drugs and Magic Remedies Act.

F) PETITIONER/APPELLANT’S ARGUMENTS

1. Violation of Undertaking:
   The counsel for the IMA argued that the contemnors willfully disregarded their undertaking to cease advertisements and press statements.

2. Public Harm:
   It was contended that these misleading claims endangered public health and eroded trust in judicial orders.

3. Statutory Breach:
   The advertisements contravened Sections 3 and 4 of the Drugs and Magic Remedies Act and Rule 6 of the Rules, 1955.

G) RESPONDENT’S ARGUMENTS

1. Unintentional Violation:
   The counsel for Patanjali argued that the violations were inadvertent and not intended to breach the undertaking.

2. Corrective Measures:
   The respondents highlighted their steps to retract advertisements and issue public apologies in national newspapers.

3. Unconditional Apology:
   Both Baba Ramdev and Acharya Balkrishna expressed regret and tendered unconditional apologies to the Court.

H) JUDGMENT

a. Ratio Decidendi:
The Court found that the respondents had committed wilful disobedience of the November 21, 2023 order. However, subsequent corrective actions and public apologies mitigated their liability, leading to the acceptance of their unqualified apology.

b. Obiter Dicta:
The Court reiterated the sanctity of undertakings given in judicial proceedings, emphasizing that any breach, regardless of intent, constitutes contempt.

c. Guidelines Issued:

• Strict adherence to undertakings given to the Court.
• Prohibition of advertisements for drugs not complying with the Drugs and Magic Remedies Act.
• Mandatory corrective measures, including public apologies and withdrawal of advertisements.

I) CONCLUSION & COMMENTS

The judgment underscores the importance of upholding judicial orders. It serves as a cautionary tale for corporations engaging in misleading practices. While the Court showed leniency in accepting the apology, it issued stern warnings about future compliance.

J) REFERENCES

a. Important Cases Referred:

• Murray and Company v. Ashok Kr. Newatia (2000) 2 SCC 367
• Rama Narang v. Ramesh Narang (2006) 11 SCC 114
• Reliance Petrochemicals Ltd. v. Indian Express (1988) 4 SCC 592

b. Important Statutes Referred:

• Contempt of Courts Act, 1971
• Drugs and Magic Remedies (Objectionable Advertisement) Act, 1954
• Article 129, Constitution of India